This move is archived. Current quotes and coverage live on the stock page.
Get TELO alerts:
Telo Genomics Corp faces a significant setback as its stock drops over 11% in a single trading session.
In a disappointing turn of events, Telo Genomics Corp (TELO.V) saw its stock price fall by 11.11%, closing at CA$0.04. This decline raises concerns among investors about the company's direction and future prospects, especially considering its recent operational expansions and leadership changes.
Advertisement
Telo Genomics Corp
TELO.V
TELO.V
Telo Genomics Corp
WealthAwesomeMarket cap
$5.02M
52W high
$0.10
52W low
$0.04
1W change
+11.11%
Beta
0.18
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELO's historical volatility
30-Day Vol
134.9%
Annualized
90-Day Vol
124.9%
Annualized
Trend (90d)
+0.0%
Annualized drift
90d Mean
C$0.05
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.05 | C$0.03 – C$0.08 |
| 60 trading days | C$0.05 | C$0.03 – C$0.10 |
| 90 trading days | C$0.05 | C$0.02 – C$0.11 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should keep a close eye on Telo Genomics Corp's performance and be cautious about potential volatility, particularly since there hasn't been any recent positive news to counter this downturn.
Telo Genomics Corp's stock tumbles 11.11% in one day
The stock's decline reflects broader investor sentiment and worries about the company's ability to achieve sustainable growth.
Bull case
Telo Genomics is expanding its operations and has recently moved to a larger facility in Toronto. This could set the stage for future growth if the company can effectively leverage these developments.
Bear case
The sharp drop in stock price, especially without any accompanying news, indicates investor concerns about the company's fundamentals. This is particularly troubling given its low market cap of CA$4.5 million and ongoing lack of profitability.
Advertisement
Market Reaction
The 11.11% drop in Telo Genomics' stock price shows a negative reaction from the market. Investors might be reevaluating the company's growth potential after its recent operational changes, like relocating its clinical laboratories to a new facility in Toronto. Despite these expansions, the absence of positive news or financial indicators likely contributed to the stock's decline.
Future Outlook
As Telo Genomics navigates this downturn, investors will be watching closely for updates on its operational performance or strategic initiatives. The company's recent leadership changes and facility expansions could lay the groundwork for recovery, but without clear signs of profitability or growth, uncertainty will likely remain. For more detailed insights, visit our Telo Genomics stock page.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
